After court loss, RFK Jr. gives himself more power over CDC vaccine panel

Getty | Elijah Nouvelage
Robert F. Kennedy Jr. has made radical changes to the charter of the federal vaccine advisory panel (ACIP), granting himself nearly absolute power over the selection of its members. This decision comes just a month after Federal Judge Brian Murphy blocked Kennedy’s previous appointments, ruling that his chosen candidates lacked the required expertise and did not represent an objective balance of scientific opinion. Previous actions by the HHS Secretary, including the dismissal of all 17 existing CDC experts and the withdrawal of recommendations for COVID-19 and Hepatitis B vaccines, have sparked a wave of criticism from global public health organizations. The new charter, published in the Federal Register, introduces a key linguistic change: ACIP members are now to be not only selected but "appointed" directly by the HHS Secretary. This legal maneuver aims to bypass restrictive merit-based requirements and enable the filling of positions with allies who hold vaccine-skeptical views. For users and patients worldwide, this poses a risk of destabilizing medical standards that have hitherto been based on scientific consensus. Taking control of ACIP could lead to the permanent removal of key preparations from official immunization schedules, directly impacting global infectious disease prevention strategies. This is a clear signal that political control over scientific structures is becoming the new standard in public health management.
In the world of health policy, such violent reshuffles that directly strike at the foundations of infectious disease prevention are rare. Health Secretary Robert F. Kennedy Jr., known for his skeptical approach to vaccinology, has just taken a decisive step to overhaul the Advisory Committee on Immunization Practices (ACIP). The new content of this body's charter, published in the Federal Register, suggests an attempt to bypass recent restrictions imposed by the judicial system and seize full control over the personnel composition of the most important vaccination advisory panel at the Centers for Disease Control and Prevention (CDC).
This move comes just a month after Kennedy's stinging defeat in federal court. District Judge Brian Murphy blocked the appointments made by the secretary at that time, ruling that the newly appointed members did not possess the required expertise. This decision froze the committee's activities and restored previous medical recommendations that Kennedy's people had already managed to withdraw. Today's change to the charter is a clear signal that the administration does not intend to abandon its radical change in health policy course, even if it involves bending existing bureaucratic standards.
Judicial Blockade and Scientific Impasse
The conflict surrounding ACIP intensified when Kennedy decided on an unprecedented step: firing all 17 experts sitting on the committee. In their place, he attempted to appoint individuals who shared his controversial views on vaccine safety. Judge Brian Murphy, in his reasoning, left no illusions about the quality of these appointments. He stated directly that a committee composed of individuals without expert status cannot be considered a body representing "fairly balanced points of view" within the scientific community. According to the judge, Kennedy's nominees did not so much present a differing opinion as they did not belong to the relevant expert community at all.
Read also

The consequences of this judicial intervention were immediate and severe for the new HHS (Department of Health and Human Services) political line. Changes introduced by Kennedy's team were suspended, which included the withdrawal of recommendations for COVID-19 vaccines and the dose of the Hepatitis B vaccine administered shortly after birth. These decisions had previously been sharply criticized by global medical and public health organizations as endangering population safety. Currently, the advisory panel is in a state of suspension, paralyzing the process of updating immunization guidelines.
The Semantics of Power in the New Charter
The new document published in the Federal Register differs significantly from the routine charter renewals that have been a pure formality for the last two decades. Although the current term of the charter does not end until April 1, 2026, the sudden modification of the language suggests an attempt to legalize actions that the court previously questioned. A key change concerns the method of selecting committee members. In previous versions, the text stated that members "shall be selected by the Secretary." The new version adds two significant words: "shall be selected and appointed by the HHS Secretary."
- Unilateral Appointment: The addition of the phrase regarding appointment aims to solidify the secretary's right to fill positions single-handedly, without the need to consider existing verification procedures.
- Blurring of Criteria: The changes in the charter seem to loosen the requirements for specialized knowledge, intended to facilitate the introduction of individuals from outside the scientific mainstream into the panel.
- Frequency of Changes: The fact that the charter was changed before its expiration date highlights the HHS's determination to quickly seize control over the vaccine agenda.
For health market analysts, this subtle change in legal text is a clear defensive move. Since Judge Murphy ruled that current rules require members to be experts in specific fields, Kennedy is modifying those rules so that his right to choose is paramount over objective substantive criteria. This is an attempt to create a new legal reality where ideological loyalty can be equated with scientific achievement in the selection process for ACIP.

Consequences for Medical Standards
The situation in which a political appointee receives such broad powers to shape scientific panels raises alarm across the biotechnology and medical sectors. ACIP is not just an advisory body — its recommendations directly influence vaccination schedules, insurance policies, and public trust in evidence-based medicine (EBM). If the member selection process becomes completely politicized, the credibility of recommendations coming from the CDC could be irreparably damaged. This, in turn, opens the door to the fragmentation of healthcare standards, where decisions on administering a vaccine depend on the current political orientation of the department rather than the results of clinical trials.
It is worth noting that the previous system relied on a fragile consensus where science provided the data and politics merely implemented it. Robert F. Kennedy Jr. is reversing this hierarchy. By changing the charter, he aims for a situation where politics defines what science is and who has the right to speak on its behalf. If these changes remain in force, we may witness a permanent restructuring of American public health institutions, which will echo in global medical standards that often model themselves on guidelines coming from the USA.
The current HHS strategy is based on the assumption that the bureaucratic system is capable of absorbing and legalizing any personnel change, provided it is appropriately described in charter documents. However, resistance from federal judges and medical organizations suggests that the fight for control over ACIP is only just beginning. The new charter is just another chapter in the dispute over whether public health should be managed by experts with recognized achievements or by individuals pursuing a specific political agenda under the banner of pluralism of opinion.
In the coming months, how the courts react to the new provisions will be crucial. If Judge Murphy or other representatives of the judiciary rule that adding the word "appointed" does not exempt the secretary from the obligation to maintain a substantive balance in the committee, Kennedy may face another legal barrier. For now, however, by changing the charter, the health secretary has equipped himself with tools intended to allow him to bypass the system's existing safeguards and independently decide who will shape the future of vaccinations in the country.








